These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2906216)

  • 21. Differential kinetics of hypocretins in the cerebrospinal fluid after intracerebroventricular administration in rats.
    Yoshida Y; Fujiki N; Maki RA; Schwarz D; Nishino S
    Neurosci Lett; 2003 Aug; 346(3):182-6. PubMed ID: 12853114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression among alcoholics. Relationship to clinical and cerebrospinal fluid variables.
    Roy A; DeJong J; Lamparski D; George T; Linnoila M
    Arch Gen Psychiatry; 1991 May; 48(5):428-32. PubMed ID: 2021295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prednisone effects on neurochemistry and behavior. Preliminary findings.
    Wolkowitz OM; Rubinow D; Doran AR; Breier A; Berrettini WH; Kling MA; Pickar D
    Arch Gen Psychiatry; 1990 Oct; 47(10):963-8. PubMed ID: 1977371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomics in neuropsychiatric disorders.
    Rohlff C
    Int J Neuropsychopharmacol; 2001 Mar; 4(1):93-102. PubMed ID: 11343634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoamine metabolites and neuropeptides in patients with Parkinson's disease, Huntington's chorea, Shy-Drager syndrome, and torsion dystonia.
    Lindvall B; Olsson JE
    Adv Neurol; 1990; 53():117-22. PubMed ID: 1700581
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptides and cerebrospinal fluid.
    Burbach JP
    Ann Clin Biochem; 1982 Jul; 19 (Pt 4)():269-77. PubMed ID: 6181730
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventricular size and CSF transmitter metabolite concentrations in severe endogenous depression.
    Standish-Barry HM; Bouras N; Hale AS; Bridges PK; Bartlett JR
    Br J Psychiatry; 1986 Apr; 148():386-92. PubMed ID: 2425882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transmitter amines in depression.
    Curzon G
    Psychol Med; 1982 Aug; 12(3):465-70. PubMed ID: 6127746
    [No Abstract]   [Full Text] [Related]  

  • 30. Depressive phenomenology and levels of cerebrospinal fluid endorphins.
    Agren H; Terenius L; Wahlström A
    Ann N Y Acad Sci; 1982; 398():388-98. PubMed ID: 6961865
    [No Abstract]   [Full Text] [Related]  

  • 31. [Specific neurohumoral activity of the cerebrospinal fluid of patients with manic-depressive psychosis].
    Vartanian GA; Zhdanova IV; Petrov ES
    Fiziol Cheloveka; 1986; 12(1):167-70. PubMed ID: 2870946
    [No Abstract]   [Full Text] [Related]  

  • 32. [The molecular mechanisms of vasovagal syncope].
    Huang P; Shi H; Wang HW
    Zhonghua Er Ke Za Zhi; 2006 May; 44(5):387-9. PubMed ID: 16780724
    [No Abstract]   [Full Text] [Related]  

  • 33. CSF GABA and neuropeptides in pathological gamblers and normal controls.
    Roy A; DeJong J; Ferraro T; Adinoff B; Gold P; Rubinow D; Linnoila M
    Psychiatry Res; 1989 Nov; 30(2):137-44. PubMed ID: 2616683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of psychotropic drugs on excitatory amino acids in patients undergoing psychosurgery for depression.
    Pangalos MN; Malizia AL; Francis PT; Lowe SL; Bertolucci PH; Procter AW; Bridges PK; Bartlett JR; Bowen DM
    Br J Psychiatry; 1992 May; 160():638-42. PubMed ID: 1350494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease.
    Barbaccia ML; Costa E; Ferrero P; Guidotti A; Roy A; Sunderland T; Pickar D; Paul SM; Goodwin FK
    Arch Gen Psychiatry; 1986 Dec; 43(12):1143-7. PubMed ID: 3022663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
    Yoon HS; Hattori K; Sasayama D; Kunugi H
    J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Depression and cerebrospinal fluid citrate.
    Mellerup ET; Rafaelsen OJ
    Acta Psychiatr Scand; 1981 Jan; 63(1):57-60. PubMed ID: 7234465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural cell adhesion molecule (NCAM) and prealbumin in cerebrospinal fluid from depressed patients.
    Jørgensen OS
    Acta Psychiatr Scand Suppl; 1988; 345():29-37. PubMed ID: 3067538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF neurotransmitter markers in Alzheimer's disease.
    Beal MF; Growdon JH
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):259-70. PubMed ID: 2879317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptides in the cerebrospinal fluid and regulation of behavior.
    Schwarzberg H; Pross M
    Prog Brain Res; 1992; 91():455-7. PubMed ID: 1357723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.